Microscopic RNA molecules sometimes travel up to a metre to get from the nucleus of a nerve cell to its tip, where they’re needed to make a protein.
And they do that by hitchhiking, suggests a research team from the Howard Hughes Medical Institute in the US.
And, they say, it may be this transit that goes awry in people with the neurodegenerative disease amyotrophic lateral sclerosis (ALS).
RNA transportation is a key part of keeping a cell functioning properly. If it isn’t distributed correctly, key proteins might not end up in the right places.
In their latest study, the researchers show how an “adaptor protein” called Annexin A11 allows RNA to latch on to lysosomes, which move easily around a cell, thus plugging into a transportation network that would otherwise be inaccessible.
People with ALS often have mutations in the gene for Annexin A11, says Lippincott-Schwartz, and now, it’s becoming clear how these mutations affect patients.
“You can think of this paper as defining a new function for lysosomes,” she says.
Curated content from the editorial staff at Cosmos Magazine.
Read science facts, not fiction...
There’s never been a more important time to explain the facts, cherish evidence-based knowledge and to showcase the latest scientific, technological and engineering breakthroughs. Cosmos is published by The Royal Institution of Australia, a charity dedicated to connecting people with the world of science. Financial contributions, however big or small, help us provide access to trusted science information at a time when the world needs it most. Please support us by making a donation or purchasing a subscription today.